Angiocrine Bioscience, Inc.

Return to Grants

Total Awards:

4

Award Value:

$25,919,710

Institution type:

For profit

Short Name:

Angiocrine

Awards to the Institution

Program Type	Investigator	Grant Title	Award Value
Clinical Trial Stage Projects	Dr. Paul Finnegan	AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205	$10,930,014
Clinical Trial Stage Projects	Dr. Edward Kavalerchik	AB-205-001 Phase 1b Trial and Related Activities to Support Clinical Development of AB-205	$6,192,579
Clinical Trial Stage Projects	Dr. Edward Kavalerchik	AB-110-001 Phase 1b Trial and Related Activities to Support Clinical Development of AB-110	$5,000,000
Late Stage Preclinical Projects	Dr. Paul W Finnegan	Development of AB-110: genetically-modified endothelial cells plus expanded cord blood hematopoietic stem cells as a transplantation therapy	$3,797,117
			Total: $25,919,710.00